Nanotechnology Now - Press Release: "Lumera Corporation to Exhibit at PEGS in Boston May 14-18"

Home > Press > Lumera Corporation to Exhibit at PEGS in Boston May 14-18

Abstract:
The Protein Engineering Summit

Lumera Corporation to Exhibit at PEGS in Boston May 14-18

BOTHELL, WA | Posted on May 7th, 2007

Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today that it will be exhibiting at the Protein Engineering Summit 2007 (PEGS). The conference is being held in Boston and begins on Monday, May 14, 2007, and continues through Friday, May 18, 2007.

In addition, Ron Dudek, Lumera's Director of Business Development, will be giving a luncheon workshop presentation on Monday, May 14, entitled "Surface Plasmon Resonance (SPR) Analysis of High-Density Antibody Microarrays: Combining Antibody Screening and Kinetic Characterization in One Platform." Additional information on the conference can be obtained at http://www.pegsummit.com/ .

####

About Lumera Corporation
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit http://www.lumera.com .

Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company’s forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company’s SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.

For more information, please click here

Contacts:
The Summit Group Communications
Todd Wolfenbarger
801-595-1155
Cell: 801-244-9600

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: